Search Results

Displaying Results 876-900 of 1115 "'IX'"

Dec 07, 2025, 14:00 ET Prologis announces redemption of 3.00% Notes due 2026

co-investment ventures, including our ability to establish new co-investment ventures; (viii) risks of doing business internationally, including currency risks; (ix) environmental uncertainties, including risks of natural disasters; (x) risks related to global pandemics; and (xi) those additional factors discussed

More news about: Prologis, Inc.


Dec 07, 2025, 12:01 ET Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years

five-year follow-up analysis demonstrated:Durable Factor IX Activity: Mean factor IX activity levels were sustained at greater than 36% during years one through five post-infusion: mean factor IX levels of 41.5 IU/dL (n=50) at year one, 36.7 IU/dL (n=50) at year two, 38.6 IU/dL

More news about: CSL


Dec 05, 2025, 12:42 ET SciBase publishes information document regarding the offer to repurchase outstanding warrants of series TO 2

2003/71/EC, as amended (the "Prospectus Regulation"). The information document has been prepared in accordance with the requirements of Annex IX of the Prospectus Regulation. The information document has been prepared in both Swedish and English. In the event of a conflict between the versions,

More news about: SciBase


Dec 05, 2025, 08:33 ET Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High‑Throughput Phenotyping Platform for DOE's M2PC

proceedings against Ginkgo, (viii) our ability to realize the expected benefits from and the success of our Foundry platform programs and Codebase assets, (ix) our ability to successfully develop engineered cells, bioprocesses, data packages or other deliverables, (x) the product development, production or

More news about: Ginkgo Bioworks


Dec 05, 2025, 07:00 ET NETFLIX TO ACQUIRE WARNER BROS. FOLLOWING THE SEPARATION OF DISCOVERY GLOBAL FOR A TOTAL ENTERPRISE VALUE OF $82.7 BILLION (Equity Value of $72.0 Billion)

personnel; (viii) potential adverse reactions or changes to business relationships resulting from the announcement, pendency or completion of the Merger; (ix) uncertainty as to the long-term value of Netflix's common stock; (x) legislative, regulatory and economic developments affecting Netflix's and WBD's

More news about: Netflix, Inc.


Dec 05, 2025, 07:00 ET NETFLIX TO ACQUIRE WARNER BROS. FOLLOWING THE SEPARATION OF DISCOVERY GLOBAL FOR A TOTAL ENTERPRISE VALUE OF $82.7 BILLION (Equity Value of $72.0 Billion)

personnel; (viii) potential adverse reactions or changes to business relationships resulting from the announcement, pendency or completion of the Merger; (ix) uncertainty as to the long-term value of Netflix's common stock; (x) legislative, regulatory and economic developments affecting Netflix's and WBD's

More news about: Netflix, Inc.


Dec 04, 2025, 16:30 ET Prologis to Announce Fourth Quarter 2025 Results January 21st, 2026

co-investment ventures, including our ability to establish new co-investment ventures; (viii) risks of doing business internationally, including currency risks; (ix) environmental uncertainties, including risks of natural disasters; (x) risks related to global pandemics; and (xi) those additional factors

More news about: Prologis, Inc.


Dec 04, 2025, 16:05 ET Saul Centers Declares Quarterly Dividends

redevelopment opportunities, and risks related to acquisitions not performing in accordance with our expectations, (viii) increases in operating costs, (ix) changes in the dividend policy for the Company's common and preferred stock and the Company's ability to pay dividends at current levels, (x) the reduction

More news about: Saul Centers, Inc.


Dec 04, 2025, 11:00 ET Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement

Sports Nutr. 2025;22(1):2434734.ixWhen used in conjunction with resistance training

More news about: Abbott


Dec 04, 2025, 08:57 ET Sola Salons Drives Q4 Expansion with Record Growth, Landmark Studio Openings, and Strategic Technology and Benefits Partnerships

Ep6ix, offering access to comprehensive health and insurance options for Sola Pros. The brand also reached landmark real-estate milestones, including

More news about: Sola Salons


Dec 04, 2025, 07:07 ET Deck the Aisles with Natural Grocers®: Holly Deals Event, Dec. 6-22, 2025

phone number at checkout for purchases to qualify. Progress may be viewed on customer's {N}power dashboard or Natural Grocers Mobile App.[ix] Offer valid 12/6/25 – 12/22/25 for in-store customer purchases only at participating Natural Grocers locations. Must be 21 or older for alcohol

More news about: Natural Grocers by Vitamin Cottage, Inc.


Dec 03, 2025, 20:00 ET Prologis Declares Quarterly Dividend

co-investment ventures, including our ability to establish new co-investment ventures; (viii) risks of doing business internationally, including currency risks; (ix) environmental uncertainties, including risks of natural disasters; (x) risks related to global pandemics; and (xi) those additional factors discussed

More news about: Prologis, Inc.


Dec 03, 2025, 08:16 ET Natural Grocers® Invites Grand Junction, CO Community to Celebrate Grand Reopening on December 17, 2025

www.naturalgrocers.com/sweepstakes. Sponsor: Vitamin Cottage Natural Food Markets, Inc.[ix] Offers valid only from 12/17/25 to 1/31/26, are redeemable only for in-store customer purchases at Natural Grocers' Grand Junction, CO location,

More news about: Natural Grocers by Vitamin Cottage, Inc.


Dec 03, 2025, 07:00 ET Shoulder Innovations Announces Strategic Partnership with INS to Introduce a Robotic Platform for Shoulder Arthroplasty

develop and commercialize additional products in a timely manner; (viii) risks associated with the Company's third-party manufacturers and suppliers; (ix) demand forecasts for the Company's implant systems; (x) the Company's ability to demonstrate to shoulder specialists or key opinion leaders the merits

More news about: Shoulder Innovations


Dec 02, 2025, 22:30 ET SCゼウス、日本第1号データセンター「Zeus OSA1」を大阪で着工

Zeus OSA1 は、約4,000坪(13,957㎡)の準工業地域に位置し、大阪中心部の IX や主要データセンター群へのアクセスに優れた立地に開発されます。この立地特性を生かし、増大する AI・クラウド需要に対応する西日本の主要デジタルインフラ拠点となることが期待されています。 AIワークロードの高度化に伴い、Zeus OSA1 は液冷(Direct-to-Chipを含む)に完全対応した冷却アーキテクチャを採用し、ラック当たり最大130kWの高電力密度に対応します。また、PUE

More news about: SC Zeus Data Centers Pte Ltd


Dec 01, 2025, 17:00 ET Highland Opportunities and Income Fund Announces the Regular Monthly Distribution

condemnation losses; (vii) variations in rental income, neighborhood values or the appeal of property to tenants; (viii) the availability of financing and (ix) changes in interest rates and leverage.Illiquidity of Investments Risk. The investments made by the Fund may be illiquid,

More news about: Highland Opportunities and Income Fund


Dec 01, 2025, 09:48 ET Caterpillar Raises $15.2 Million for United Way, Named a 2025 Leading Corporate Partner

the highly competitive environment in which we operate on our sales and pricing; (viii) information technology security threats and computer crime; (ix) inventory management decisions and sourcing practices of our dealers and our OEM customers; (x) a failure to realize, or a delay in realizing, all of

More news about: Caterpillar Inc.


Dec 01, 2025, 08:30 ET JPIX Selects XKL for IX Network Infrastructure Upgrade

[email protected] JPIXJPIX began IX services in November 1997 as Japan's first commercial Internet Exchange (IX), and has operated as a neutral IX provider with one of the largest numbers of customers, including ISP operators, cable TV operators,

More news about: XKL, LLC


Dec 01, 2025, 07:00 ET RedHill Biopharma Successfully Regains Compliance with Nasdaq Stockholders' Equity Requirement

the Company's therapeutic candidates and the results obtained with its therapeutic candidates in research, pre-clinical studies or clinical trials; (ix) the implementation of the Company's business model, strategic plans for its business and therapeutic candidates; (x) the scope of protection the Company

More news about: RedHill Biopharma Ltd.


Nov 27, 2025, 09:54 ET ACCOUNTING NET INCOME OF R$13.5 BILLION IN 9M25 AND R$3.8 BILLION IN 3Q25, REPRESENTING YEAR-OVER-YEAR GROWTH OF 50.3% AND 15.4%, RESPECTIVELY

billion as of Sep25, up 11.8% YoY;     VIII.     Total Loan Origination of R$185.1 billion in 3Q25, up 13.3% YoY;     IX.     Mortgage Loan Portfolio balance of R$905.0 billion as of Sep25, up 11.4% YoY;     X.     CAIXA holds a market share of 67.1%

More news about: Caixa Econômica Federal


Nov 27, 2025, 09:54 ET LUCRO LÍQUIDO CONTÁBIL DE R$ 13,5 BILHÕES NO 9M25 E R$ 3,8 BILHÕES NO 3T25, CRESCIMENTO DE 50,3% E 15,4%, RESPECTIVAMENTE, NA COMPARAÇÃO 12 MESES.

185,1 bilhões em originação de crédito total no 3T25, crescimento de 13,3% em relação ao 3T24;     IX.     Saldo de R$ 905,0 bilhões na carteira de crédito imobiliário em Set25, 11,4% maior que Set24;      X.     No Crédito

More news about: Caixa Econômica Federal


Nov 26, 2025, 21:39 ET SK Biopharmaceuticals Expands Radiopharmaceutical Therapy Portfolio with Second In-licensed Candidate from Wisconsin Alumni Research Foundation

radiopharmaceutical value chain.WT-7695 is a small-molecule radiopharmaceutical candidate in preclinical stage designed to target carbonic anhydrase IX (CA9), a transmembrane protein that plays a critical role in cancer cell growth and metastasis under hypoxic conditions. CA9 is highly expressed in clear

More news about: SK Biopharmaceuticals. Co., Ltd.


Nov 26, 2025, 11:41 ET FIBRA Prologis anuncia la emisión y colocación de USD$500 millones en Notas Senior No Garantizadas a 10 años en los mercados internacionales

calificaciones crediticias, (vii) riesgos relacionados con nuestras inversiones, (viii) incertidumbres ambientales, incluyendo riesgos de desastres naturales, y (ix) los factores adicionales mencionados en los informes presentados por FIBRA Prologis ante la Comisión Nacional Bancaria y de Valores ("CNBV")

More news about: FIBRA Prologis


Nov 26, 2025, 11:37 ET FIBRA Prologis anuncia la emisión y colocación de USD$500 millones en Notas Senior No Garantizadas a 10 años en los mercados internacionales

calificaciones crediticias, (vii) riesgos relacionados con nuestras inversiones, (viii) incertidumbres ambientales, incluyendo riesgos de desastres naturales, y (ix) los factores adicionales mencionados en los informes presentados por FIBRA Prologis ante la Comisión Nacional Bancaria y de Valores ("CNBV")

More news about: FIBRA Prologis


Nov 26, 2025, 11:23 ET FIBRA Prologis announces the issuance and sale of USD$500 million of 10-Year Senior Unsecured Notes in the International Markets

maintain and our credit ratings, (vii) risks related to our investments (viii) environmental uncertainties, including risks of natural disasters, and (ix) those additional factors discussed in reports filed with the Mexican National Banking and Securities Commission (Comisión Nacional Bancaria y de

More news about: FIBRA Prologis


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.